摘要
糖尿病肾病(DN)具有遗传易感性,其发生有家族聚集性和种族差异,是一种复杂的多基因疾病。既往的候选基因研究关注于已知生物学通路的靶基因,而全基因组关联研究(GWAS)技术能够高效、无偏倚地调查全基因组,有望鉴定出新的基因和病理机制。基因表达的表观遗传学调控是DN遗传易感性的一个重要原因,下一代测序技术是研究罕见变异的理想工具。遗传学研究能够提供参与DN的特定通路的信息,有助于阐明DN的病理生理机制,开发早期诊断、预防和治疗的新策略,从而降低DN的发病率和病死率。
Susceptibility to diabetic nephropathy (DN) has an inherent genetic basis as evidenced by familial aggregation and ethnic-specific prevalence rates. DN has been widely considered as a polygenic disease. Previous ' candidate genes' studies selected genes with plausible physiological roles in DN. The GWAS approach allows for cost effective, unbiased sur- veys of the entire genome, with the hope of identifying novel genes which further elucidate the underlying biology of DN. Epi- genetic regulation of gene expression may represent an important contributor to an inherited predisposition to DN. The next- generation sequencing technology is an ideal tool to search for rare variants. Genetic studies may provide valuable informa- tion regarding the pathophysiology of DN and will lead to early detection and development of novel therapeutic strategies.
出处
《中国实用内科杂志》
CAS
CSCD
北大核心
2014年第3期243-246,共4页
Chinese Journal of Practical Internal Medicine
关键词
糖尿病肾病
遗传
候选基因
全基因组关联研究
表观遗传学
diabetic nephropathy
genetics
candidate genes
genome-wide association studies
epigenetics